Learn more about whether Inari Medical, Inc. or DENTSPLY SIRONA Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Learn more about whether Bausch + Lomb Corporation or Inari Medical, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Inari Medical (TASE:PMCN) Inc. (NARI) has reached a new 52-week high, with its stock price climbing to $79.7, marking a significant milestone for the $4.68 billion medical device company.

Stryker reported goodwill and other impairments of $818 million related to the spine business in the fourth quarter.

Inc. (NARI) has reached a new 52-week high, with its stock price climbing to $79.7, marking a significant milestone for the ...

In a remarkably news-filled earnings call on Jan. 28, Stryker Corp. revealed plans to sell its U.S. and spinal implants business to Viscogliosi Brothers LLC for an undisclosed sum, announced the ...

KNOWN for its innovative take on the classic Japanese sukiyaki experience, Inari Sukiyaki has officially opened its second store at the 4th level of SM Aura Premier, 26th Street corner McKinley ...